2009
DOI: 10.1253/circj.cj-09-0059
|View full text |Cite
|
Sign up to set email alerts
|

Molecular Basis of Restenosis and Novel Issues of Drug-Eluting Stents

Abstract: Teruo Inoue, MD; Koichi Node, MD Restenosis after stent deployment is an overreaction of the wound healing response after vascular injury, and is characterized by the sequence of inflammation, granulation, extracellular matrix remodeling, and smooth muscle cell (SMC) proliferation and migration. In contrast, reendothelialization of at least part of the injured vessel surface, which is essential in the wound healing process, may occur at the site of stenting. Recent advances in drug-eluting stents (DES) have su… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
115
0
2

Year Published

2010
2010
2024
2024

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 166 publications
(117 citation statements)
references
References 77 publications
0
115
0
2
Order By: Relevance
“…This result suggests that platonin could be a potential agent for treating VSMC proliferation-related diseases. Inflammatory processes followed by the proliferation of vascular components such as VSMCs and the extracellular matrix are associated with neointimal thickening [23] . Furthermore, reactive oxygen species (ROS) are reported to be a key mediator of signaling pathways that underlie vascular inflammation [24] .…”
Section: Discussionmentioning
confidence: 99%
“…This result suggests that platonin could be a potential agent for treating VSMC proliferation-related diseases. Inflammatory processes followed by the proliferation of vascular components such as VSMCs and the extracellular matrix are associated with neointimal thickening [23] . Furthermore, reactive oxygen species (ROS) are reported to be a key mediator of signaling pathways that underlie vascular inflammation [24] .…”
Section: Discussionmentioning
confidence: 99%
“…3,4 A particularly promising area for the therapeutic application of multilayered polyelectrolyte films is in the coating of drug-eluting coronary stents 5 as an attempt to prevent restenosis after percutaneous transluminal angioplasty. 6,7 For this purpose, it is essential that the stent coating must not only be biocompatible but should also be a surface that is conducive for the adhesion of endothelial cells so as to facilitate healing of the blood vessel and prevent restenosis and thrombosis.…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, the following drop in NO and H 2 S bioavailability stimulates VSMCs to switch from a contractile quiescent to a proliferative (synthetic) motile phenotype. As a consequence, VSMC migrate from the media towards the inner surface of the vessel, where they continue to proliferate and secrete extracellular matrix proteins, leading to neointimal tissue formation [26].…”
Section: Endothelial Dysfunctionmentioning
confidence: 99%
“…The consequent thickening of the vascular wall, which has been termed in-stent restenosis (ISR), perturbs blood supply to vital and peripheral organs and dramatically affects cardiovascular homeostasis [26]. Another form of endothelial dysfunctions is caused by hyper-activation of EC by a variety of risk factors, including hypercholesterolemia, aging, hypertension, turbulent blood flow, smoking, type I and type II diabetes, glycaemia, and hyperhomocysteinemia, etc [1].…”
Section: Endothelial Dysfunctionmentioning
confidence: 99%